Inventor · disambiguated record
Jill Marie Sturdivant
Also filed as: STURDIVANT JILL · STURDIVANT JILL M · STURDIVANT JILL MARIE
56 granted patents·20 pending applications·953 citations·filing 2005–2024
99Inventor score
Top patents by PatentIndex Score
76 records- 0199US10174017B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2018·Granted Jan 8, 2019·41 cites·31 claims
- 0298US11197853B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2021·Granted Dec 14, 2021·5 cites·22 claims
- 0398US11185538B2Compositions for treating glaucoma or reducing intraocular pressureAERIE PHARMACEUTICALS INC·Filed 2021·Granted Nov 30, 2021·5 cites·22 claims
- 0498US11028081B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jun 8, 2021·6 cites·24 claims
- 0598US10112920B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2017·Granted Oct 30, 2018·20 cites·22 claims
- 0698US9884840B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2016·Granted Feb 6, 2018·25 cites·6 claims
- 0798US9643927B1Process for the preparation of kinase inhibitors and intermediates thereofAERIE PHARMACEUTICALS INC·Filed 2015·Granted May 9, 2017·33 cites·22 claims
- 0898US9096569B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2014·Granted Aug 4, 2015·40 cites·36 claims
- 0998US8716310B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2013·Granted May 6, 2014·49 cites·12 claims
- 1098US8450344B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsDELONG MITCHELL A·Filed 2008·Granted May 28, 2013·51 cites·37 claims
- 1198US8394826B2Dual mechanism inhibitors for the treatment of diseaseDELONG MITCHELL A·Filed 2010·Granted Mar 12, 2013·57 cites·33 claims
- 1298US7671205B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2007·Granted Mar 2, 2010·61 cites·3 claims
- 1397US11312700B2Aryl cyclopropyl-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2020·Granted Apr 26, 2022·6 cites·28 claims
- 1497US10899714B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jan 26, 2021·10 cites·24 claims
- 1597US9415043B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2014·Granted Aug 16, 2016·32 cites·1 claims
- 1697US8921392B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2012·Granted Dec 30, 2014·38 cites·12 claims
- 1797US8759388B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsDELONG MITCHELL A·Filed 2012·Granted Jun 24, 2014·39 cites·17 claims
- 1897US8455647B26-aminoisoquinoline compoundsDELONG MITCHELL A·Filed 2011·Granted Jun 4, 2013·44 cites·3 claims
- 1997US8455513B26-aminoisoquinoline compoundsDELONG MITCHELL A·Filed 2007·Granted Jun 4, 2013·44 cites·21 claims
- 2097US8357699B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2011·Granted Jan 22, 2013·42 cites·19 claims
- 2197US8034943B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2010·Granted Oct 11, 2011·49 cites·4 claims
- 2296US11021456B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jun 1, 2021·5 cites·33 claims
- 2396US10654844B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2019·Granted May 19, 2020·11 cites·28 claims
- 2496US10316029B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·10 cites·21 claims
- 2596US9993470B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2017·Granted Jun 12, 2018·13 cites·20 claims
- 2696US8455514B26-and 7-amino isoquinoline compounds and methods for making and using the sameDELONG MITCHELL A·Filed 2008·Granted Jun 4, 2013·43 cites·14 claims
- 2795US10882840B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jan 5, 2021·10 cites·25 claims
- 2895US10858339B2Aryl cyclopropyl-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2018·Granted Dec 8, 2020·9 cites·3 claims
- 2995US10588901B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·9 cites·22 claims
- 3095US10532993B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2018·Granted Jan 14, 2020·9 cites·25 claims
- 3195US9963432B2Beta-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2017·Granted May 8, 2018·10 cites·6 claims
- 3295US9951059B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2017·Granted Apr 24, 2018·10 cites·6 claims
- 3395US9931336B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2016·Granted Apr 3, 2018·11 cites·21 claims
- 3495US8871757B26-and 7-amino isoquinoline compounds and methods for making and using the sameDELONG MITCHELL A·Filed 2010·Granted Oct 28, 2014·36 cites·48 claims
- 3594US11020385B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jun 1, 2021·7 cites·8 claims
- 3693US9849122B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2016·Granted Dec 26, 2017·7 cites·21 claims
- 3792US11590123B2Ophthalmic compositionsAERIE PHARMACEUTICALS INC·Filed 2022·Granted Feb 28, 2023·1 cites·16 claims
- 3892US10568878B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2018·Granted Feb 25, 2020·6 cites·28 claims
- 3992US9512101B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2015·Granted Dec 6, 2016·6 cites·16 claims
- 4092US9365518B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2014·Granted Jun 14, 2016·10 cites·21 claims
- 4191US11618748B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2021·Granted Apr 4, 2023·1 cites·24 claims
- 4291US10472327B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2017·Granted Nov 12, 2019·6 cites·13 claims
- 4390US11389441B2Ophthalmic compositionsAERIE PHARMACEUTICALS INC·Filed 2017·Granted Jul 19, 2022·6 cites·3 claims
- 4490US9890123B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2016·Granted Feb 13, 2018·5 cites·11 claims
- 4586US11427563B2Aryl cyclopropyl-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2019·Granted Aug 30, 2022·2 cites·32 claims
- 4686US8722739B2Amino acid salts of prostaglandinsDELONG MITCHELL A·Filed 2008·Granted May 13, 2014·5 cites·8 claims
- 4785US8623918B2Amino acid salts of prostaglandinsDELONG MITCHELL A·Filed 2008·Granted Jan 7, 2014·4 cites·11 claims
- 4884US11059789B2Isoquinoline-steroid conjugates and uses thereofAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jul 13, 2021·1 cites·30 claims
- 4981US11707460B2Ophthalmic compositionsAERIE PHARMACEUTICALS INC·Filed 2022·Granted Jul 25, 2023·0 cites·29 claims
- 5081US2022088000A1Combination therapyAERIE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 76 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →